New FDA Rare Disease Framework Initiative

Oct 19 2026
New FDA Rare Disease Framework Initiative

Just announced from the US FDA: FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development

Oct. 14th, 2026: The U.S. Food and Drug Administration, a division within the U.S. Department of Health and Human Services (HHS), today announced the Rare Disease Framework Initiative to reimagine the development of drugs and biologics for rare diseases. As outlined in a new white paper, the Initiative will develop an optimized, fit-for-purpose framework that reflects the realities of rare disease drug development by considering the nuances of each disease, patient needs, product type and the evidence that can be realistically generated in small patient populations.

Read the full release

Learn what this could means for the Wake Up Narcolepsy community this Thursday, October 22nd